NSF’s dietary supplement standards for 2008 in-line with FDA
ANN ARBOR, Mich. NSF International on Thursday announced that the 2008 version of NSF’s American National Standard for Dietary Supplements now includes new good manufacturing practices requirements to ensure consistency with Food and Drug Administration regulations.
The FDA regulations take effect June 25, for companies who employ more than 500 employees; companies with less than 500 employees will have additional time.
“NSF is committed to keeping its standards in line with key regulations such as FDA requirements for GMPs and AER,” stated Jane Wilson, NSF director of standards. “That is why NSF/ANSI Standards are continuously being reviewed and updated to ensure that they are consistent with new legislation and the latest technical developments.”
“These requirements verify that manufacturers are in compliance, enable regulators to rely on independent certification, and help consumers make informed decisions when choosing a supplement with the NSF Mark,” commented Kristen Holt, senior vice president, NSF Dietary Supplements Programs. “The NSF Mark on a product demonstrates that the product has met and will continue to meet all program requirements.”
The new version of NSF/ANSI Standard 173: Dietary Supplements contains revisions to Section 8 GMP requirements that reference the new FDA requirements for both dietary supplement GMPs, as well as the Adverse Event Reporting requirements that went into effect in December.
These updates will also be incorporated into NSF’s Dietary Supplement Certification Program, which is based on NSF/ANSI Standard 173. Certification of products to this standard provides consumers confidence that what is on the label matches what is in the product. Certification also ensures that dietary supplements are produced in accordance with GMPs and are certified free of harmful contaminants.
To date, the NSF Dietary Supplement Certification Program has issued nearly 400 certifications of products that are sold worldwide.
GSK applauds updated PHS guidlines for quitting smoking
PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare on Wednesday released a statement commending the updated 2008 U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence.
“Too many smokers lower their chances of quitting by relying on cold turkey approaches to become tobacco-free,” GSK stated. “The Guideline is an important validation of the need for clinicians to recommend the use of effective tobacco dependence counseling and medication [and] reflects considerable progress in tobacco cessation research over the past decade to help identify the most effective strategies at reducing tobacco dependence.”
The updated guideline reflects the distillation of thousands of research articles, and continues to recommend nicotine replacement products as a first-line therapy for quitting, as they “increase significantly rates of long-term smoking abstinence.”
Study suggests link between vitamin D deficiency and depression
CHICAGO According to a study published in the May edition of the Archives of General Psychiatry, depression has been linked to a vitamin D deficiency in older adults.
The Netherlands study examined 1,282 community residents between the ages of 65 years and 95 years.
Levels of vitamin D were 14 percent lower in 169 persons with minor depression, as well as in 26 persons with major depressive order.